PMID- 23726961 OWN - NLM STAT- MEDLINE DCOM- 20130905 LR - 20151119 IS - 0027-5107 (Print) IS - 0027-5107 (Linking) VI - 755 IP - 1 DP - 2013 Jul 4 TI - New DNA probes to detect aneugenicity in rat bone marrow micronucleated cells by a pan-centromeric FISH analysis. PG - 73-80 LID - S1383-5718(13)00144-7 [pii] LID - 10.1016/j.mrgentox.2013.05.011 [doi] AB - When characterizing the genotoxicity of chemicals that induce micronuclei, it is practical to be able to classify the chemicals as aneugens or clastogens. This classification gives information on the mechanistic properties of chemicals and is indispensable for setting the threshold safety margins for genotoxicity in pharmaceutical development. A widely used method for detecting aneugens is fluorescence in situ hybridization (FISH) but, even though the rat is an experimental animal generally used in preclinical studies in drug development, DNA probes that hybridize to all the centromeres of rat chromosomes have not yet been established. In the present study, in addition to the previously known satellite I sequence, we identified two novel satellite sequences, satellite II and satellite III, from the rat genome database. DNA probes with a mixture of these satellite DNA sequences were used to establish a FISH method for pan-centromeric staining of rat chromosomes. To confirm the feasibility of the method, vinblastine (VBS) and mitomycin C (MMC) were administered to rats as a typical aneugen and clastogen, respectively. Micronucleated polychromatic erythrocytes (MNPCE) from bone marrow were enriched by sorting in flow cytometry and subjected to the FISH method. As a result, the ratio of centromere-positive MNPCE increased in VBS-treated rats but not in MMC-treated ones. Since the FISH method using the novel DNA probes clearly discriminates the aneugens from the clastogens, we suggest this method as a useful tool for providing mechanistic information for micronucleus induction in vivo. CI - Copyright (c) 2013 Elsevier B.V. All rights reserved. FAU - Takeiri, Akira AU - Takeiri A AD - Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan. takeiriakr@chugai-pharm.co.jp FAU - Motoyama, Shigeki AU - Motoyama S FAU - Matsuzaki, Kaori AU - Matsuzaki K FAU - Harada, Asako AU - Harada A FAU - Taketo, Junko AU - Taketo J FAU - Katoh, Chiaki AU - Katoh C FAU - Tanaka, Kenji AU - Tanaka K FAU - Mishima, Masayuki AU - Mishima M LA - eng PT - Journal Article DEP - 20130529 PL - Netherlands TA - Mutat Res JT - Mutation research JID - 0400763 RN - 0 (Aneugens) RN - 0 (Antibiotics, Antineoplastic) RN - 0 (DNA Probes) RN - 0 (DNA, Satellite) RN - 0 (Mutagens) RN - 0 (Tubulin Modulators) RN - 50SG953SK6 (Mitomycin) RN - 5V9KLZ54CY (Vinblastine) RN - SML2Y3J35T (Colchicine) SB - IM MH - Aneugens/*toxicity MH - Animals MH - Antibiotics, Antineoplastic/toxicity MH - Base Sequence MH - Bone Marrow/*drug effects MH - Centromere/*drug effects/genetics MH - Chromosomes/genetics MH - Colchicine/toxicity MH - *DNA Probes MH - DNA, Satellite/analysis/genetics MH - Erythrocytes/drug effects MH - Flow Cytometry MH - *In Situ Hybridization, Fluorescence MH - Male MH - Micronuclei, Chromosome-Defective/*drug effects MH - Micronucleus Tests MH - Mitomycin/toxicity MH - Molecular Sequence Data MH - Mutagens/*toxicity MH - Rats MH - Sequence Homology, Nucleic Acid MH - Tubulin Modulators/toxicity MH - Vinblastine/toxicity OTO - NOTNLM OT - Aneugen OT - Centromere OT - FISH OT - Rat OT - Satellite DNA EDAT- 2013/06/04 06:00 MHDA- 2013/09/06 06:00 CRDT- 2013/06/04 06:00 PHST- 2013/03/06 00:00 [received] PHST- 2013/04/27 00:00 [revised] PHST- 2013/05/14 00:00 [accepted] PHST- 2013/06/04 06:00 [entrez] PHST- 2013/06/04 06:00 [pubmed] PHST- 2013/09/06 06:00 [medline] AID - S1383-5718(13)00144-7 [pii] AID - 10.1016/j.mrgentox.2013.05.011 [doi] PST - ppublish SO - Mutat Res. 2013 Jul 4;755(1):73-80. doi: 10.1016/j.mrgentox.2013.05.011. Epub 2013 May 29.